Chan Wah Hak Charleen Min Li, Tan Yew Oo, Chan Charles
School of Clinical Medicine, University of Cambridge, Cambridge, UK.
BMJ Case Rep. 2012 Sep 24;2012:bcr0220125802. doi: 10.1136/bcr-02-2012-5802.
A patient with long-standing immune thrombocytopenic purpura (ITP) would logically contradict antiplatelet use due to increased bleeding risk during coronary stenting. Coronary stenting using an endothelial progenitor cells (EPC) capture stents (Genous™) was used to successfully revascularise our patient using a transradial approach. The only complication was extensive superficial ecchymosis on the patient's forearm from antiplatelet use, which resolved spontaneously. To the best of our knowledge, this is the first case report of EPC capture stents in a chronic ITP patient.
一名患有长期免疫性血小板减少性紫癜（ITP）的患者，由于冠状动脉支架置入期间出血风险增加，在逻辑上与使用抗血小板药物相矛盾。我们使用内皮祖细胞（EPC）捕获支架（Genous™）通过桡动脉途径成功地为该患者进行了冠状动脉支架置入术，实现血管再通。唯一的并发症是患者前臂因使用抗血小板药物出现广泛的皮下瘀斑，该瘀斑自行消退。据我们所知，这是首例关于慢性ITP患者使用EPC捕获支架的病例报告。
